Latest News for: pharmaceutics

Edit

Cultivating circular agriculture with a zoo in Japan (Takeda Pharmaceutical Co Ltd)

Public Technologies 26 Mar 2025
) Watch the three-minute video to see how we collaborate with a local zoo to utilize the natural compost for circular agriculture ... [...] ... Takeda Pharmaceutical Co.
Edit

NEW PHARMACEUTICAL WAREHOUSE TO IMPROVE MEDICAL SUPPLY DISTRIBUTION IN THE NORTH (22 03 2025) (Office of the Prime Minister of the Republic of Fiji)

Public Technologies 26 Mar 2025
"The 25m x 20m Warehouse is aligned to the Fiji Pharmaceutical and Biomedical Services building height standard and will play a critical role in the storage and distribution of medical supplies ...
Edit

Commercial Day Presentation (Kalvista Pharmaceuticals Inc)

Public Technologies 26 Mar 2025
). Today's Presenters. Ben Palleiko ... KalVista Pharmaceuticals ... KalVista Pharmaceuticals. KalVista Pharmaceuticals ... KalVista is a global pharmaceutical company delivering novel therapies that empower people to live better lives ... Kalvista Pharmaceuticals Inc.
Edit

Comunicado ao Mercado (iShares US Pharmaceuticals ETF)

Public Technologies 26 Mar 2025
). COMUNICADO A MERCADO ATUALIZAÇÃO DOS CONSTITUINTES DO. ÍNDICE DO ETF ... ETF INDEX ... iShares US Pharmaceuticals ETF ... iShares US Pharmaceuticals ETF published this content on March 26, 2025, and is solely responsible for the information contained therein.
Edit

New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings (AstraZeneca Pharmaceuticals LP)

Public Technologies 26 Mar 2025
) PUBLISHED 25 March 2025 ... Highlights include ... Professor Virginia Harrison, EGFR Positive UK, said ... Notes. NSCLC ... 1 ... 2 ... AstraZeneca Pharmaceuticals LP published this content on March 25, 2025, and is solely responsible for the information contained therein.
Edit

Trump says he will soon announce tariffs on autos, aluminum, pharmaceuticals

Hong Kong Standard 25 Mar 2025
US President Donald Trump said on Monday he will in the very near future announce tariffs on automobiles, aluminum and pharmaceuticals ... The Standard Channel. IOS Android ... .
Edit

Lawsuit Notice: Investors who hold Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares should contact the Shareholders Foundation

Nasdaq Globe Newswire 25 Mar 2025
Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ. REGN) ... .
Edit

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan

Nasdaq Globe Newswire 25 Mar 2025
Alumis and Kaken Pharmaceutical collaborate for oral next-generation TYK2 inhibitor ESK-001 in dermatology in Japan ... .
Edit

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in

The Eagle-Tribune 25 Mar 2025
- Alumis to receive $40 million in upfront and near-term co-development payments, with potential for approximately $140 million in additional milestone and field option payments, plus tiered royalties on future sales ... .
Edit

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Nasdaq Globe Newswire 25 Mar 2025
Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites;�full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 ... .
Edit

X4 Pharmaceuticals: Q4 Earnings Snapshot

The Call 25 Mar 2025
BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter ... The results missed Wall Street expectations ... .
Edit

'Don't just get stuck in one therapy area,' Deloitte warns pharmaceutical industry

CNBC 25 Mar 2025
Colin Terry, life sciences partner at Deloitte, weighs in on investment flows in the global pharmaceutical market and the recent focus on GLP-1 weight loss drugs ... .
Edit

Actinium Pharmaceuticals to Host KOL Investor Call at 8am ET Today to Highlight Revamped Clinical ...

Victoria Advocate 25 Mar 2025
- Actinium will present 3 separate multi-billion-dollar market opportunities for Actimab-A and Iomab-ACT in myeloid malignancies, solid tumors and cell & gene therapy conditioning ....
×